Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

VALN vs VTYX: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VTYX Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

VTYX Overall Winner 6-Pillar Tally: VALN 3 – 3 VTYX Matrix Metrics: VALN 3 – 7 VTYX

As of Nov 16, 2026, Ventyx Biosciences, Inc. (VTYX) is the stronger overall head-to-head candidate over Valneva SE (VALN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). VALN carries a Unified Composite Score of 50.9/100 (HOLD) at $5.65 (4.8x Forward P/E, -80.4% operating margin), whereas VTYX carries 50.4/100 (HOLD) at $14.00 (N/M Forward P/E, 0.0% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VALN vs VTYX
VALN NASDAQ
Valneva SE American Depositary Shares
Biological Products, (No Diagnostic Substances)
$5.65
-0.18% 1D
Market Cap $547.9M
TTM Revenue $143M
Forward P/E 4.8x
Beta / 30D Vol 0.45β · 42% Vol
Unified Composite Score
50.9 / 100 HOLD
Tech 42.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 53
RSI-14: 52.7 · SMA20: $5.60 · SMA50: $5.95
VTYX NASDAQ Head-to-Head Winner
Ventyx Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$14.00
+0.14% 1D
Market Cap $1.0B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.07β · 2% Vol
Unified Composite Score
50.4 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (19.0% over 20 days), RSI 71
RSI-14: 70.7 · SMA20: $13.96 · SMA50: $12.72

6-Pillar Scorecard Institutional Category Breakdown (VALN 3 – 3 VTYX)

Columns: Metric · VALN · VTYX
1. Valuation Multiples VALN
Forward P/E 4.8x N/M
Trailing P/E 8.4x N/M
PEG Ratio N/M N/M
EV / Revenue 3.8x N/M
2. Growth & Scale VTYX
Revenue Growth (YoY) -27.7% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $143M N/A
Market Cap $547.9M $1.0B
3. Profitability & Quality VTYX
Gross Margin -41.7% N/A
Operating Margin -80.4% 0.0%
Net Profit Margin -110.3% 0.0%
Return on Equity (ROE) -117.9% -45.4%
4. Balance Sheet & Cash Flow VALN
Cash Generation (TTM) -$99M EBITDA N/A
Cash Flow Margin -69.1% EBITDA Mgn N/A
Net Cash / Leverage $0.96 Book/Sh · -117.9% ROE $2.68 Book/Sh · -45.4% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning VTYX
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 0.5% (<1st %ile)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat VALN
OpEx & R&D Intensity 38.7% of Rev ($55M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VALN (3) vs VTYX (7)
Institutional Metric VALN VTYX Criterion Row Edge
Market Capitalization
Scale
$547.9M $1.0B Larger Scale VTYX
Trailing P/E Ratio
Valuation
8.4x N/M Lower Multiple VALN
Forward P/E Ratio
Valuation
4.8x N/M Lower Multiple VALN
Revenue Growth (YoY)
Growth
-27.7% +0.0% Higher Growth VTYX
Operating Margin (TTM)
Profitability
-80.4% 0.0% Higher Margin VTYX
Net Profit Margin
Profitability
-110.3% 0.0% Higher Margin VTYX
Return on Equity (ROE)
Capital Efficiency
-117.9% -45.4% Higher ROE VTYX
52-Week Range Position
Momentum
12% ($5–$12) 55% ($1–$25) Stronger Trend VTYX
Beta / 30D Volatility
Risk Regime
0.45β · 42% Vol 2.07β · 2% Vol Lower Realized Risk VTYX
Unified Institutional Score
Composite Signal
50.9 / 100 (HOLD) 50.4 / 100 (HOLD) Higher Composite VALN
Trailing 12M Revenue (USD)
Operating Scale
$143M N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-41.7% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.8x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$99M EBITDA ($0.96 Book/Sh · -117.9% ROE) N/A ($2.68 Book/Sh · -45.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VALN +10.93 pp
VALN: +11.29% · VTYX: +0.36%
3M Horizon VTYX +30.43 pp
VALN: +9.57% · VTYX: +40.0%
6M Horizon VTYX +35.55 pp
VALN: +11.05% · VTYX: +46.6%
1Y Horizon VTYX +35.55 pp
VALN: +11.05% · VTYX: +46.6%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VALN vs VTYX. Trailing 12-month operating profitability (VALN -80.4% vs VTYX 0.0%) and valuation multiples (VALN 4.8x vs VTYX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

VALN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$143M
Gross Margin-41.7%
Op. Margin-80.4%
ROE / Fwd P/E-117.9% · 4.8x
VTYX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-45.4% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VALN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VALN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VTYX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 0.5%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VTYX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VALN Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $547.9M market capitalization and -80.4% operating margin.
OpEx & R&D Reinvestment 38.7% of Rev ($55M)
90D Engineering Disclosures 0 Published
VTYX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.0B market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ VALN vs VTYX Key Questions & Quantitative Answers

As of Nov 16, 2026, Ventyx Biosciences, Inc. (VTYX) is the stronger overall head-to-head candidate over Valneva SE (VALN) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). VALN carries a Unified Composite Score of 50.9/100 (HOLD) at $5.65 (4.8x Forward P/E, -80.4% operating margin), whereas VTYX carries 50.4/100 (HOLD) at $14.00 (N/M Forward P/E, 0.0% operating margin). Technically, VALN sits in a Neutral phase (RSI 52.7, UNCLASSIFIED options structure) and VTYX sits in a Markup phase (RSI 70.7, UNCLASSIFIED options structure).

VTYX leads the Growth & Scale pillar: VALN posts -27.7% YoY revenue growth and +0.0% YoY earnings growth on $143M TTM revenue (-41.7% gross margin, -80.4% operating margin), compared with VTYX at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, VALN generates $143M in USD-normalized revenue versus N/A for VTYX. In operating R&D and SG&A reinvestment, VALN deploys 38.7% of Rev ($55M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VTYX.

VALN screens cheaper on headline valuation multiples. VALN trades at 4.8x Forward P/E, 8.4x Trailing P/E, N/M PEG, and 3.8x EV/Revenue (-69.1% EBITDA margin), whereas VTYX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VALN (-117.9% ROE) versus VTYX (-45.4% ROE) capital efficiency.

In options market volatility and institutional positioning, VALN carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.45β · 42% Vol realized risk). By comparison, VTYX carries 0.5% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.07β · 2% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.